4//SEC Filing
Nark Ted C 4
Accession 0001209191-22-028159
CIK 0001723128other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:48 PM ET
Size
9.4 KB
Accession
0001209191-22-028159
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-05-08−35,406→ 0 total→ Class A Common Stock (35,406 underlying) - Exercise/Conversion
Class A Common Stock
2022-05-08+35,406→ 144,190 total - Award
Restricted Stock Units
2022-05-09+80,128→ 80,128 total→ Class A Common Stock (80,128 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022.
- [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 6:48 PM ET
- Size
- 9.4 KB